Abstract
Saccharomyces boulardii is a non-pathogenic yeast which has been used as both a preventive and therapeutic agent for the treatment of a variety of diarrhoeal diseases. The studies with animal models and evidence from human volunteers and patients indicate a profile which is effective in the therapy of diarrhoea and is remarkably safe for oral ingestion. The pharmacokinetic data demonstrate that 5. boulardü reaches a steady-state concentration quickly and maintains a high stable level as long as the yeast is taken daily. Once the agent is discontinued, S. boulardü is quickly eliminated from the colon. Clinical trials studying antibiotic-associated diarrhoea, nasogastric-tube alimentation diarrhoea, Clostridium difficile-disease, acute diarrhoea and chronic diarrhoea in HI V-infected patients are reviewed. ©1993 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
Author supplied keywords
Cite
CITATION STYLE
Mcfarland, L. V., & Bernasconi, P. (1993). Saccharomyces boulardii’. A review of an innovative biotherapeutic agent. Microbial Ecology in Health and Disease, 6(4), 157–171. https://doi.org/10.3109/08910609309141323
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.